GLP-1 weight loss telehealth in Connecticut
FDA-approved brand-name Wegovy®, Zepbound®, and Foundayo™ prescribed by physicians licensed in Connecticut. $29/mo membership — the lowest fee in GLP-1 telehealth. No contracts.
Last clinically reviewed: May 14, 2026 by the Imbue Health Medical Team
How Connecticut licensure works on Imbue
Imbue Health serves Connecticut residents statewide — Bridgeport, New Haven, Hartford, and every town between — under licensure from the Connecticut Medical Examining Board.
Every Connecticut prescription Imbue writes goes through a U.S.-licensed, board-certified physician. Medications ship directly from the manufacturer's pharmacy program — NovoCare (Novo Nordisk) for Wegovy® and Oral Wegovy®, LillyDirect (Eli Lilly) for Foundayo™ and Zepbound®. We never use compounding pharmacies.
Major Connecticut metros served include Bridgeport, New Haven, Hartford, Stamford, Waterbury — but we prescribe statewide, not just in major cities.
FDA-approved GLP-1 medications available in Connecticut
All five brand-name SKUs are shipped to Connecticut addresses by NovoCare or LillyDirect.
Foundayo™
The only FDA-approved GLP-1 pill you can take any time of day — no food or water restrictions.
$149/mo via LillyDirect · $178/mo total · 12.4% avg. weight loss
Oral Wegovy®
The first FDA-approved GLP-1 pill for weight loss — no injections required.
$149/mo via NovoCare · $178/mo total · 15.1% avg. weight loss
Wegovy®
The standard of care for chronic weight management — proven cardiovascular benefit.
$199/mo via NovoCare · $228/mo total · 15% avg. weight loss
Zepbound®
The highest-efficacy FDA-approved GLP-1 — dual GIP/GLP-1 action.
$299/mo via LillyDirect · $328/mo total · 22% avg. weight loss
Zepbound® KwikPen
The same dual GIP/GLP-1 efficacy as Zepbound® Vials — in a convenient pre-filled pen.
$299/mo via LillyDirect · $328/mo total · 22% avg. weight loss
Eligibility for GLP-1 medication in Connecticut
- Adults 18 and older residing in Connecticut.
- BMI ≥30, or BMI ≥25 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease).
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- Able to receive shipments from NovoCare and LillyDirect at a Connecticut address.
Imbue Health also serves
Related pages
Start brand-name GLP-1 in Connecticut at $178/mo
$29/mo Imbue Health membership + brand-name medication shipped directly from NovoCare or LillyDirect to your Connecticut address. No contracts.